Fig. 1From: Five-year outcome of conventional and drug-eluting transcatheter arterial chemoembolization in patients with hepatocellular carcinomaKaplan-Meier curve of overall survival time (a) and PFS time (b) by treatments. a The estimated median overall survival time was derived as 37Ā months (95%CIā=ā32.2ā41.8Ā months) for cTACE and 37Ā months (95%CIā=ā23.5ā50.5Ā months) for DEB-TACE. The log-rank test p-valueā=ā0.091. b The estimated median PFS time was derived as 11Ā months (95%CIā=ā9.6ā12.4Ā months) for cTACE and 16Ā months (95%CIā=ā13.1ā18.9Ā months) for DEB-TACE. The log-rank test p-valueā=ā0.019Back to article page